Papel de BAX en la respuesta apoptótica a los agentes anticancerígenos
1Howard Hughes Medical Institute, Oncology Center, and Program in Human Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Science (New York, N.Y.)
|November 4, 2000
Resumen
El gen BAX es crucial para la apoptosis en las células de cáncer colorrectal humano. Su ausencia bloquea la muerte celular inducida por los AINE, pero solo afecta parcialmente la quimioterapia con 5-fluorouracilo.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Investigación del cáncer Investigación del cáncer.
- Farmacología Farmacología.
Sus antecedentes:
- El gen BAX juega un papel en la muerte celular programada (apoptosis).
- Comprender la función de BAX es clave para desarrollar terapias efectivas contra el cáncer.
Objetivo del estudio:
- Para investigar el papel específico del gen BAX en la apoptosis inducida por fármacos.
- Para determinar la participación de BAX en la eficacia de los agentes quimioterapéuticos y quimiopreventivos en el cáncer colorrectal.
Principales métodos:
- Líneas celulares de cáncer colorrectal humano generadas que carecen de genes BAX funcionales.
- Evaluó la respuesta apoptótica de estas células al 5-fluorouracilo y a los antiinflamatorios no esteroideos (AINE).
- Se analizaron los cambios en la expresión de la proteína antiapoptótica Bcl-XL y las relaciones BAX:Bcl-XL.
Principales resultados:
- Las células deficientes en BAX mostraron resistencia parcial a la apoptosis inducida por el 5-fluorouracilo.
- Las células deficientes en BAX eran completamente resistentes a la apoptosis inducida por el sulindac y otros AINE.
- Se encontró que los AINE disminuyen la expresión de Bcl-XL, alterando la relación BAX:Bcl-XL y desencadenando la apoptosis mediada por mitocondrias.
Conclusiones:
- BAX es esencial para la apoptosis inducida por AINE en las células de cáncer colorrectal humano.
- BAX juega un papel importante en las vías apoptóticas relevantes para la quimioprevención del cáncer.
- Dirigirse a BAX o modular sus interacciones podría mejorar las estrategias de tratamiento del cáncer.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...